Excelsior Biopharma Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 386.045 million compared to TWD 384.908 million a year ago. Operating income was TWD 16.017 million compared to TWD 22.265 million a year ago. Net income was TWD 10.743 million compared to TWD 16.362 million a year ago. Basic earnings per share was TWD 0.23 compared to TWD 0.35 a year ago. For the half year, sales was TWD 731.983 million compared to TWD 753.656 million a year ago. Operating income was TWD 32.315 million compared to TWD 42.093 million a year ago. Net income was TWD 23.359 million compared to TWD 32.414 million a year ago. Basic earnings per share was TWD 0.5 compared to TWD 0.69 a year ago.